Stanford CIRM Training Program
Grant Award Details
Grant Type:
Grant Number:
TG2-01159
Investigator(s):
Award Value:
$7,017,629
Status:
Closed
Progress Reports
Reporting Period:
Year 4
Reporting Period:
Year 5
Reporting Period:
Year 6
Reporting Period:
Year 7/NCE
Grant Application Details
Application Title:
CIRM Training Program
Public Abstract:
This application proposes to continue, and expand, our CIRM-funded integrated training and research program in the fundamental biology of embryonic stem cells, nuclear reprogramming, tissue- and organ-specific stem cells and cancer stem cells. We aim to produce the next generation of leaders positioned to understand basic stem cell mechanisms, develop relevant human stem cell lines for investigation into pathogenesis and treatment of diseases, and provide the basis for development of new molecular and cellular therapies. During the previous funding period, the CIRM Training program has been highly-successful and vital to our stem cell efforts, providing valuable resources for both Scholars and the greater community in which they are educated. Our Program offers outstanding opportunities for training predoctoral, postdoctoral and clinical Scholars, in stem cell biology, regenerative medicine, and human disease. Because the School of Medicine, Hospitals, and the University are situated on one campus, our Program brings a powerful combination of assets to this mission. Our faculty have extensive experience in basic research, clinical translation, and training in stem cell biology and medicine. Moreover, our Program is strongly committed to stem cell biology. In 2002, we established a regenerative medicine institute, which nucleated a University-wide Program in Regenerative Medicine that promotes interactions between Departments and Programs in the Schools of Engineering, Law, Humanities & Sciences, Business, Medicine, and an interdisciplinary program in biology and medicine. In addition, [REDACTED] has established a center for human embryonic stem cell research and education, which is housed in our regenerative medicine institute. Program activities form a foundation for research and include a comprehensive course on Stem Cell Biology and Regenerative Medicine to educate CIRM Scholars regarding stem cells and applications to human disease, and opportunities to provide non-medical CIRM Scholars with an understanding of the considerations necessary to translate basic research to the clinic. Courses in Biomedical Ethics, Responsible Conduct of Research, basic and advanced courses in human embryonic stem cell (hESC) and pluripotent stem cell biology, a seminar series [REDACTED], an annual retreat and a robust program in stem cells and Society offer additional and unique educational opportunities. We seek funding for our Type I comprehensive training program with 16 concurrent positions devoted to 6 predoctoral, 5 postdoctoral, and 5 clinical fellow CIRM Scholars.
Statement of Benefit to California:
This application proposes to continue and expand our CIRM-funded integrated training and research program in the fundamental biology of embryonic, adult, and reprogrammed-stem cell research and its applications to human disease. We aim to produce leaders positioned to understand basic stem cell mechanisms, develop relevant human stem cell lines in order to investigate the pathogenesis and treatment of diseases, and provide the fundamental and practical basis for the development of new molecular and cellular therapies. These activities have significant implications for the State of California and its citizens. We are requesting CIRM funds in order to continue our highly successful Research Training Program, with 6 predoctoral, 5 post-doctoral and 5 clinical fellow trainees for a total of 16 concurrent CIRM Scholar positions. Trainees will have the opportunity to learn from pre-eminent stem cell biologists as well as physicians, scientists and physician-scientists at one of the State’s leading academic institutions. Furthermore, our program in Regenerative Medicine, with which trainees are closely associated, represents a unique University-wide collaboration that brings together over 150 faculty members in life, physical, and engineering sciences, together with leaders in business, law, and education. This CIRM Research Training Program proposal will provide real benefits to the State of California and its citizens in the following ways: First, all trainees will be exposed to vital medical issues amongst Californian patients and this will foster new ideas and lead to exploration of novel strategies with associated faculty in their pursuits of novel stem cell therapies. Second, our programmatic activities including courses, seminars, annual retreats, symposia and journal club components as part of this training program, will serve to connect with a much greater number of student, fellows, and basic and clinical faculty across the disciplines, from Biochemistry to Law and Business to Medicine from across the campus in all seven schools and across the State. Third, this training program has significant potential to provide the support and momentum to explore advances in stem cell biology and novel therapies which will further attract additional world class faculty over the next decade. Finally, by bringing together our stem cell faculty and trainees in one program, and connecting and coordinating (via our program in Regenerative Medicine), our efforts across the campus will maximize our capability to develop innovative new diagnostics, tools, and novel therapies in stem cell biology and regenerative medicine and also gain the attention and momentum of researchers across the campus and beyond. These innovations ultimately promise to improve the lives of Californians and bring additional research talent and business into the State.
Publications
- Curr Opin Cell Biol (2013): All’s well that ends well: alternative polyadenylation and its implications for stem cell biology. (PubMed: 23357469)
- Proc Natl Acad Sci U S A (2009): ChIP-Seq of transcription factors predicts absolute and differential gene expression in embryonic stem cells. (PubMed: 19995984)
- World Neurosurg (2012): Cochlea Radiation Dose Correlates with Hearing Loss Following Stereotactic Radiosurgery of Vestibular Schwannoma. (PubMed: 22484770)
- Science (2010): The CRAC channel activator STIM1 binds and inhibits L-type voltage-gated calcium channels. (PubMed: 20929812)
- Cell Stem Cell (2012): Developmental Stage and Time Dictate the Fate of Wnt/beta-Catenin-Responsive Stem Cells in the Mammary Gland. (PubMed: 22863533)
- Proc Natl Acad Sci U S A (2012): Direct conversion of mouse fibroblasts to self-renewing, tripotent neural precursor cells. (PubMed: 22308465)
- Nat Commun (2014): Discriminating cellular heterogeneity using microwell-based RNA cytometry. (PubMed: 24667995)
- Nature (2015): Early reprogramming regulators identified by prospective isolation and mass cytometry. (PubMed: 25830878)
- Integr Biol (Camb) (2013): Engineering of three-dimensional microenvironments to promote contractile behavior in primary intestinal organoids. (PubMed: 24343706)
- Stem Cell Reports (2014): Generation of Induced Neuronal Cells by the Single Reprogramming Factor ASCL1. (PubMed: 25254342)
- Cell (2013): Hierarchical mechanisms for direct reprogramming of fibroblasts to neurons. (PubMed: 24243019)
- Sci Rep (2014): Human germ cell formation in xenotransplants of induced pluripotent stem cells carrying X chromosome aneuploidies. (PubMed: 25242416)
- Gastroenterology (2012): Identification of a Ckit+ Colonic Crypt Base Secretory Cell that Supports Lgr5+ Stem Cells in Mice. (PubMed: 22333952)
- Blood (2011): Identification of the earliest natural killer cell committed progenitor in murine bone marrow. (PubMed: 21931117)
- Nat Immunol (2011): IL-1beta-driven neutrophilia preserves antibacterial defense in the absence of the kinase IKKbeta. (PubMed: 21170027)
- J Exp Med (2013): Inactivation of the RB family prevents thymus involution and promotes thymic function by direct control of Foxn1 expression. (PubMed: 23669396)
- Nat Methods (2013): An indirect approach to generating specific human cell types. (PubMed: 23269377)
- Proc Natl Acad Sci U S A (2011): The intestinal stem cell markers Bmi1 and Lgr5 identify two functionally distinct populations. (PubMed: 22190486)
- Proc Natl Acad Sci U S A (2013): Lineage tracing with Axin2 reveals distinct developmental and adult populations of Wnt/beta-catenin-responsive neural stem cells. (PubMed: 23589866)
- Cell Stem Cell (2011): LRRK2 Mutant iPSC-Derived DA Neurons Demonstrate Increased Susceptibility to Oxidative Stress. (PubMed: 21362567)
- Curr Opin Genet Dev (2012): The many roads to Rome: induction of neural precursor cells from fibroblasts. (PubMed: 22868177)
- Nature (2011): MicroRNA-mediated conversion of human fibroblasts to neurons. (PubMed: 21753754)
- Curr Neurol Neurosci Rep (2012): Modeling Parkinson’s disease using induced pluripotent stem cells. (PubMed: 22538490)
- Mol Cell (2012): Molecular roadblocks for cellular reprogramming. (PubMed: 23020854)
- Genes Dev (2011): Neuropilins are positive regulators of Hedgehog signal transduction. (PubMed: 22051878)
- PLoS One (2011): A New FACS Approach Isolates hESC Derived Endoderm Using Transcription Factors. (PubMed: 21408072)
- Nat Med (2014): Oncogenic transformation of diverse gastrointestinal tissues in primary organoid culture. (PubMed: 24859528)
- Proc Natl Acad Sci U S A (2011): Overexpression of BCL2 enhances survival of human embryonic stem cells during stress and obviates the requirement for serum factors. (PubMed: 21300885)
- PLoS One (2010): Parthenogenic blastocysts derived from cumulus-free in vitro matured human oocytes. (PubMed: 20539753)
- Proc Natl Acad Sci U S A (2014): Preleukemic mutations in human acute myeloid leukemia affect epigenetic regulators and persist in remission. (PubMed: 24550281)
- Nat Med (2014): Rejuvenation of the muscle stem cell population restores strength to injured aged muscles. (PubMed: 24531378)
- Cell Stem Cell (2012): A self-limiting switch based on translational control regulates the transition from proliferation to differentiation in an adult stem cell lineage. (PubMed: 23122292)
- Nature (2013): SHANK3 and IGF1 restore synaptic deficits in neurons from 22q13 deletion syndrome patients. (PubMed: 24132240)
- Integr Biol (Camb) (2012): A single cell bioengineering approach to elucidate mechanisms of adult stem cell self-renewal. (PubMed: 22327505)
- Stem Cells (2011): In Situ Genetic Correction of the Sickle Cell Anemia Mutation in Human Induced Pluripotent Stem Cells Using Engineered Zinc Finger Nucleases. (PubMed: 21898685)
- Methods Cell Biol (2011): Spatiotemporal control of embryonic gene expression using caged morpholinos. (PubMed: 21924162)
- Science (2010): Substrate elasticity regulates skeletal muscle stem cell self-renewal in culture. (PubMed: 20647425)
- Magn Reson Med (2011): Theranostic effect of serial manganese-enhanced magnetic resonance imaging of human embryonic stem cell derived teratoma. (PubMed: 22190225)
- Nat Neurosci (2013): Timothy syndrome is associated with activity-dependent dendritic retraction in rodent and human neurons. (PubMed: 23313911)
- Cell (2012): TPP1 OB-Fold Domain Controls Telomere Maintenance by Recruiting Telomerase to Chromosome Ends. (PubMed: 22863003)
- Nat Biotechnol (2011): Tracking single hematopoietic stem cells in vivo using high-throughput sequencing in conjunction with viral genetic barcoding. (PubMed: 21964413)
- Cell (2013): Type 2 innate signals stimulate fibro/adipogenic progenitors to facilitate muscle regeneration. (PubMed: 23582327)
- Nat Med (2011): Using iPSC-derived neurons to uncover cellular phenotypes associated with Timothy syndrome. (PubMed: 22120178)
- Magn Reson Med (2011): In vivo molecular MRI of cell survival and teratoma formation following embryonic stem cell transplantation into the injured murine myocardium. (PubMed: 21604295)